decisionhealth Newsletters, Coder Pink Sheets - 2023 Issue 6 (June)
Understanding E/M: Capture correct level of risk for Rx management, parenteral controlled substances
Subscribe or sign in to view the full article.
Article Overview
This premium article discusses how E/M documentation and medical decision-making risk are interpreted when prescription drug management or parenteral controlled substances appear in the plan of care. It is aimed at coders, physicians, and qualified health care professionals who need to understand the general framework for assessing risk in different care settings and clinical scenarios. The article uses webinar-based guidance and scenario discussion to clarify how the risk element of the MDM table is evaluated.
Why This Topic Matters
Correctly understanding the risk component of E/M documentation affects code selection, compliance, and accurate representation of patient management complexity. The article helps readers recognize when medication-related management may or may not support a higher risk level.
Article Sections
-
Overview
Introduces the topic of E/M risk assessment and the role of medication-related management in the medical decision-making table.
-
Key takeaways from the webinar
Summarizes the main themes presented by webinar speakers regarding how risk is viewed in different clinical situations.
-
Inpatient Rx drug management
Presents an inpatient scenario involving medication management and discusses how the issue is considered across hospital days.
-
Parenteral controlled substances – high risk
Covers a surgical inpatient scenario involving parenteral medication use and how risk is evaluated in that context.
-
Parenteral controlled substances – moderate risk
Reviews a postoperative scenario in which parenteral medication use is discussed in relation to a lower-risk clinical setting.
-
Resource
Provides the referenced webinar resource used as the basis for the discussion.
What You Will Learn
- How medication-related management fits into E/M medical decision-making
- How risk is discussed in inpatient and postoperative contexts
- How clinicians and coders should think about documentation that supports medication-related management
- How webinar-based guidance frames different clinical scenarios involving controlled substances
Who Should Read This
- Medical coders
- Physicians
- Qualified health care professionals
- Compliance staff
- Revenue cycle staff
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com